NASDAQ: HCWB
Hcw Biologics Inc Stock Ownership - Who owns Hcw Biologics?

Insider buying vs selling

Have Hcw Biologics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Lee FlowersSVP2026-07-297,736$2.59
$20.00kBuy
Scott T. GarrettDirector2026-07-297,736$2.59
$20.00kBuy
Hing C. WongCEO2026-07-2923,210$2.59
$60.00kBuy
Rebecca ByamChief Financial Officer2026-05-2214,235$1.41
$20.00kBuy
Scott T. GarrettDirector2026-05-22177,936$1.41
$250.00kBuy
Hing C. WongChief Executive Officer2026-05-22113,879$1.41
$160.00kBuy

1 of 1

HCWB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when HCWB insiders and whales buy or sell their stock.

HCWB Shareholders

What type of owners hold Hcw Biologics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Scott T. Garrett14.74%270,590$462.71kInsider
Hing C. Wong6.85%125,845$215.19kInsider
Peter Rhode4.22%77,500$132.53kInsider
Rebecca Byam3.12%57,245$97.89kInsider
Jinan Jiao2.46%45,141$77.19kInsider
Lisa M. Giles1.95%35,815$61.24kInsider
Lee Flowers0.47%8,691$14.86kInsider
Gary M. Winer0.22%4,075$6.97kInsider
Rick S. Greene0.11%2,066$3.53kInsider
Jane Street Group LLC0.00%52$88.92Institution

1 of 3

HCWB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
HCWB0.01%34.14%Net BuyingNet Buying
VIVS0.00%100.00%Net BuyingNet Buying
ADXN0.00%17.47%
APVO0.00%100.00%Net BuyingNet Selling
PPCB0.00%0.00%

Hcw Biologics Stock Ownership FAQ

Who owns Hcw Biologics?

Hcw Biologics (NASDAQ: HCWB) is owned by 0.01% institutional shareholders, 34.14% Hcw Biologics insiders, and 65.85% retail investors. Scott T. Garrett is the largest individual Hcw Biologics shareholder, owning 270,590.00 shares representing 14.74% of the company. Scott T. Garrett's Hcw Biologics shares are currently valued at $457.30k.

If you're new to stock investing, here's how to buy Hcw Biologics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.